{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:33:49Z","timestamp":1777401229363,"version":"3.51.4"},"reference-count":52,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":243,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA018197-05"],"award-info":[{"award-number":["DA018197-05"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA026120"],"award-info":[{"award-number":["DA026120"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Addict"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1111\/ajad.12172","type":"journal-article","created":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T23:03:57Z","timestamp":1427756637000},"page":"15-23","source":"Crossref","is-referenced-by-count":34,"title":["The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review"],"prefix":"10.1111","volume":"24","author":[{"given":"Isabelle E.","family":"Bauer","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Science; University of Texas Health Sciences Center; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jair C.","family":"Soares","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Science; University of Texas Health Sciences Center; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Menninger Department of Psychiatry and Behavioral Sciences; Baylor College of Medicine and the Michael E. DeBakey Veterans Affairs Medical Center; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,3,30]]},"reference":[{"key":"10.1111\/ajad.12172-BIB0001|ajad12172-cit-0001","unstructured":"Results from the 2012 National Survey on Drug Use and Health: Summary of National findings"},{"key":"10.1111\/ajad.12172-BIB0002|ajad12172-cit-0002","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nn1583","article-title":"Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction","volume":"8","author":"Kreek","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1111\/ajad.12172-BIB0003|ajad12172-cit-0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1111\/ajad.12172-BIB0004|ajad12172-cit-0004","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugalcdep.2009.10.011","article-title":"The endogenous opioid system: A common substrate in drug addiction","volume":"108","author":"Trigo","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1111\/ajad.12172-BIB0005|ajad12172-cit-0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.biopsych.2008.01.018","article-title":"Decreased Volume of the Brain Reward System in Alcoholism","volume":"64","author":"Makris","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1111\/ajad.12172-BIB0006|ajad12172-cit-0006","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrn3110","article-title":"Pharmacogenetic approaches to the treatment of alcohol addiction","volume":"12","author":"Heilig","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1111\/ajad.12172-BIB0007|ajad12172-cit-0007","first-page":"2","article-title":"Analyzing interaction of \u03bc-, \u03b4-and \u03ba-opioid receptor gene variants on alcohol or drug dependence using a pattern discovery-based method","volume":"7","author":"Li","year":"2013","journal-title":"J Addict Res Ther S"},{"key":"10.1111\/ajad.12172-BIB0008|ajad12172-cit-0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2013.10.018","article-title":"Pharmacogenetics of OPRM1","volume":"123","author":"Crist","year":"2014","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1111\/ajad.12172-BIB0009|ajad12172-cit-0009","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction","volume":"95","author":"Bond","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/ajad.12172-BIB0010|ajad12172-cit-0010","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1097\/01.ALC.0000148114.34000.B9","article-title":"A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans","volume":"28","author":"Ray","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/ajad.12172-BIB0011|ajad12172-cit-0011","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00001756-200303240-00008","article-title":"Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations","volume":"14","author":"Tan","year":"2003","journal-title":"Neuroreport"},{"key":"10.1111\/ajad.12172-BIB0012|ajad12172-cit-0012","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neulet.2013.02.018","article-title":"Low frequency genetic variants in the \u03bc-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine","volume":"542","author":"Clarke","year":"2013","journal-title":"Neuroscience Letters"},{"key":"10.1111\/ajad.12172-BIB0013|ajad12172-cit-0013","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1530-0277.2008.00735.x","article-title":"Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers","volume":"32","author":"Arias","year":"2008","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1111\/ajad.12172-BIB0014|ajad12172-cit-0014","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/mp.2010.56","article-title":"A genetic determinant of the striatal dopamine response to alcohol in men","volume":"16","author":"Ramchandani","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1111\/ajad.12172-BIB0015|ajad12172-cit-0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.mp.4002035","article-title":"The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk","volume":"13","author":"Zhang","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1111\/ajad.12172-BIB0016|ajad12172-cit-0016","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/npp.2013.304","article-title":"An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans","volume":"39","author":"Crist","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/ajad.12172-BIB0017|ajad12172-cit-0017","doi-asserted-by":"crossref","first-page":"ra54","DOI":"10.1126\/scisignal.2000807","article-title":"Increased abundance of opioid receptor heteromers after chronic morphine administration","volume":"3","author":"Gupta","year":"2010","journal-title":"Sci Signal"},{"key":"10.1111\/ajad.12172-BIB0018|ajad12172-cit-0018","doi-asserted-by":"crossref","first-page":"10906","DOI":"10.1523\/JNEUROSCI.22-24-10906.2002","article-title":"Genetic dissociation of opiate tolerance and physical dependence in delta-opioid receptor-1 and preproenkephalin knock-out mice","volume":"22","author":"Nitsche","year":"2002","journal-title":"J Neurosci"},{"key":"10.1111\/ajad.12172-BIB0019|ajad12172-cit-0019","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/76061","article-title":"Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses","volume":"25","author":"Filliol","year":"2000","journal-title":"Nat Genet"},{"key":"10.1111\/ajad.12172-BIB0020|ajad12172-cit-0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.mp.4002035","article-title":"The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk","volume":"13","author":"Zhang","year":"2008","journal-title":"Molecular psychiatry"},{"key":"10.1111\/ajad.12172-BIB0021|ajad12172-cit-0021","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1369-1600.2012.00445.x","article-title":"Association of OPRD1 polymorphisms with heroin dependence in a large case-control series","volume":"19","author":"Nelson","year":"2014","journal-title":"Addiction biology"},{"key":"10.1111\/ajad.12172-BIB0022|ajad12172-cit-0022","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugalcdep.2012.06.023","article-title":"Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations","volume":"127","author":"Crist","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1111\/ajad.12172-BIB0023|ajad12172-cit-0023","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00018-011-0844-x","article-title":"The dynorphin\/kappa-opioid receptor system and its role in psychiatric disorders","volume":"69","author":"Tejeda","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1111\/ajad.12172-BIB0024|ajad12172-cit-0024","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/00001756-199408150-00018","article-title":"Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors","volume":"5","author":"Unterwald","year":"1994","journal-title":"Neuroreport"},{"key":"10.1111\/ajad.12172-BIB0025|ajad12172-cit-0025","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J Neurosci"},{"key":"10.1111\/ajad.12172-BIB0026|ajad12172-cit-0026","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.mp.4001882","article-title":"Association of the kappa-opioid system with alcohol dependence","volume":"11","author":"Xuei","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1111\/ajad.12172-BIB0027|ajad12172-cit-0027","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/JCP.0000000000000082","article-title":"The Association of Genetic Polymorphisms in the \u03ba-Opioid Receptor 1 Gene With Body Weight, Alcohol Use, and Withdrawal Symptoms in Patients With Methadone Maintenance","volume":"34","author":"Wang","year":"2014","journal-title":"Journal of clinical psychopharmacology"},{"key":"10.1111\/ajad.12172-BIB0028|ajad12172-cit-0028","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1601-183X.2008.00410.x","article-title":"Genetic susceptibility to heroin addiction: a candidate gene association study","volume":"7","author":"Levran","year":"2008","journal-title":"Genes, Brain and Behavior"},{"key":"10.1111\/ajad.12172-BIB0029|ajad12172-cit-0029","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1038\/tp.2013.62","article-title":"A variant on the kappa opioid receptor gene (OPRK1) is associated with stress response and related drug craving, limbic brain activation and cocaine relapse risk","volume":"3","author":"Xu","year":"2013","journal-title":"Translational psychiatry"},{"key":"10.1111\/ajad.12172-BIB0030|ajad12172-cit-0030","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1097\/01.ALC.0000139704.88862.01","article-title":"Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers","volume":"28","author":"Drobes","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/ajad.12172-BIB0031|ajad12172-cit-0031","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002130100919","article-title":"Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis","volume":"160","author":"O'Malley","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/ajad.12172-BIB0032|ajad12172-cit-0032","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","article-title":"Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study","volume":"60","author":"Kiefer","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/ajad.12172-BIB0033|ajad12172-cit-0033","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00213-003-1720-7","article-title":"Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking","volume":"173","author":"Anton","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/ajad.12172-BIB0034|ajad12172-cit-0034","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.64.9.1069","article-title":"Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study","volume":"64","author":"Ray","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/ajad.12172-BIB0035|ajad12172-cit-0035","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00213-008-1330-5","article-title":"A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients","volume":"201","author":"Kim","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/ajad.12172-BIB0036|ajad12172-cit-0036","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1530-0277.2006.00156.x","article-title":"Genetic moderators of naltrexone's effects on alcohol cue reactivity","volume":"30","author":"McGeary","year":"2006","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/ajad.12172-BIB0037|ajad12172-cit-0037","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","article-title":"A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients","volume":"28","author":"Oslin","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/ajad.12172-BIB0038|ajad12172-cit-0038","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpsyc.65.2.135","article-title":"An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study","volume":"65","author":"Anton","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/ajad.12172-BIB0039|ajad12172-cit-0039","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1530-0277.2008.00846.x","article-title":"OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach","volume":"33","author":"Oroszi","year":"2009","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1111\/ajad.12172-BIB0040|ajad12172-cit-0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/npp.2011.192","article-title":"Pharmacogenetics of naltrexone in Asian Americans: a randomized placebo-controlled laboratory study","volume":"37","author":"Ray","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/ajad.12172-BIB0041|ajad12172-cit-0041","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1530-0277.2010.01233.x","article-title":"Naltrexone selectively elevates GABAergic neuroactive steroid levels in heavy drinkers with the Asp40 allele of the OPRM1 gene: a pilot investigation","volume":"34","author":"Ray","year":"2010","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1111\/ajad.12172-BIB0042|ajad12172-cit-0042","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1530-0277.2008.00682.x","article-title":"Naltrexone Alone and With Sertraline for the Treatment of Alcohol Dependence in Alaska Natives and Non-Natives Residing in Rural Settings: A Randomized Controlled Trial","volume":"32","author":"O'Malley","year":"2008","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1111\/ajad.12172-BIB0043|ajad12172-cit-0043","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1530-0277.2007.00545.x","article-title":"Moderators of Naltrexone's Effects on Drinking, Urge, and Alcohol Effects in Non-Treatment-Seeking Heavy Drinkers in the Natural Environment","volume":"32","author":"Tidey","year":"2008","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1111\/ajad.12172-BIB0044|ajad12172-cit-0044","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1530-0277.2007.00339.x","article-title":"Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study","volume":"31","author":"Gelernter","year":"2007","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1111\/ajad.12172-BIB0045|ajad12172-cit-0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/tpj.2013.30","article-title":"Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females","volume":"14","author":"Clarke","year":"2013","journal-title":"The pharmacogenomics journal"},{"key":"10.1111\/ajad.12172-BIB0046|ajad12172-cit-0046","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2217\/pgs.13.58","article-title":"Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction","volume":"14","author":"Levran","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1111\/ajad.12172-BIB0047|ajad12172-cit-0047","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.euroneuro.2012.02.002","article-title":"Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients","volume":"22","author":"Wang","year":"2012","journal-title":"European Neuropsychopharmacology"},{"key":"10.1111\/ajad.12172-BIB0048|ajad12172-cit-0048","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2217\/pgs.11.96","article-title":"Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients","volume":"12","author":"Hung","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1111\/ajad.12172-BIB0049|ajad12172-cit-0049","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/FPC.0b013e32834c5445","article-title":"OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence","volume":"21","author":"Coller","year":"2011","journal-title":"Pharmacogenetics and genomics"},{"key":"10.1111\/ajad.12172-BIB0050|ajad12172-cit-0050","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.pnpbp.2008.07.009","article-title":"Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment","volume":"32","author":"Crettol","year":"2008","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1111\/ajad.12172-BIB0051|ajad12172-cit-0051","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopsych.2005.04.032","article-title":"Vaccine pharmacotherapy for the treatment of cocaine dependence","volume":"58","author":"Martell","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1111\/ajad.12172-BIB0052|ajad12172-cit-0052","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/YPG.0000000000000008","article-title":"The K-opioid receptor gene as a predictor of response in a cocaine vaccine trial","volume":"23","author":"Nielsen","year":"2013","journal-title":"Psychiatr Genet"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajad.12172","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajad.12172\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T03:25:22Z","timestamp":1717817122000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajad.12172"}},"subtitle":["Opioidergic Genes and Addiction Pharmacotherapy"],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"URL":"https:\/\/doi.org\/10.1111\/ajad.12172","relation":{},"ISSN":["1055-0496"],"issn-type":[{"value":"1055-0496","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}